ACSL4 and pancreatic neoplasm: In pancreatic tumor, cancer-associated fibroblast (CAF)-derived long-chain fatty acid–CoA ligase 4 (ACSL4)-targeting miRNAs suppress ferroptosis and induce gemcitabine resistance [10].